Predict your next investment

Venture Capital
sightlinepartners.com

See what CB Insights has to offer

Investments

162

Portfolio Exits

46

Funds

16

About SightLine Partners

SightLine Partners is an alternative investment manager providing custom equity financing for differentiated, growth-stage healthcare companies.

SightLine Partners Headquarter Location

8500 Normandale Lake Blvd Suite 1070

Minneapolis, Minnesota, 55437,

United States

952-641-0300

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest SightLine Partners News

Magnolia Medical Raises $20M in Series C Financing

Jan 30, 2019

Magnolia Medical Technologies , a Seattle, WA-based sepsis testing accuracy care company, raised $20m in Series C financing. The round was led by RTW Investments with participation from existing institutional investors HealthQuest Capital, SightLine Partners and Canepa Healthcare. In conjunction with the funding, Naveen Yalamanchi, M.D., Partner at RTW Investments, will join the Board of Directors as an observer. The company intends to use the funds to scale market initiatives and advance its portfolio of innovative blood and bodily fluid collection and contamination prevention devices. Led by Greg Bullington, CEO, Magnolia Medical is a medical device company that develops, manufactures and markets innovative blood and bodily fluid collection devices to facilitate significant improvements in the accuracy, consistency and predictability of critical IVD laboratory tests. provides Steripath® Gen2 Initial Specimen Diversion Device® (ISDD®), which has been adopted in hospitals across the U.S. to address the problem of blood culture contamination. The product is enabling hospitals to eliminate blood culture contamination to reduce false positive diagnostic results for sepsis and reduce inappropriate antibiotic use. The company also plans to develop and commercialize innovative products that improve the accuracy and consistency of other important in vitro diagnostic (IVD) tests, leveraging an extensive intellectual property portfolio it has built over the past decade. FinSMEs

SightLine Partners Investments

162 Investments

SightLine Partners has made 162 investments. Their latest investment was in Magnolia Medical Technologies as part of their Series D on January 1, 2022.

CBI Logo

SightLine Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/25/2022

Series D

Magnolia Medical Technologies

$46M

No

2

11/16/2021

Series C

4C Medical

$35M

No

2

12/30/2020

Series A

Koya Medical

$11.02M

Yes

5

12/10/2020

Series B - IV

Subscribe to see more

$99M

Subscribe to see more

10

12/7/2020

Series J

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/25/2022

11/16/2021

12/30/2020

12/10/2020

12/7/2020

Round

Series D

Series C

Series A

Series B - IV

Series J

Company

Magnolia Medical Technologies

4C Medical

Koya Medical

Subscribe to see more

Subscribe to see more

Amount

$46M

$35M

$11.02M

$99M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

2

5

10

10

SightLine Partners Portfolio Exits

46 Portfolio Exits

SightLine Partners has 46 portfolio exits. Their latest portfolio exit was CVRx on June 30, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/30/2021

IPO

$99M

Public

12

5/16/2019

Acq - Fin

$99M

1

7/6/2016

Acquired

$99M

1

2/27/2015

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

11/12/2014

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/30/2021

5/16/2019

7/6/2016

2/27/2015

11/12/2014

Exit

IPO

Acq - Fin

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

12

1

1

10

10

SightLine Partners Acquisitions

2 Acquisitions

SightLine Partners acquired 2 companies. Their latest acquisition was Kadent Corporation on February 09, 2006.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

2/9/2006

$99M

Acquired

6/30/1993

Series B

Subscribe to see more

$99M

$99M

Subscribe to see more

10

Date

2/9/2006

6/30/1993

Investment Stage

Series B

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

$99M

Note

Acquired

Subscribe to see more

Sources

10

SightLine Partners Fund History

16 Fund Histories

SightLine Partners has 16 funds, including 10K Lakes Fund I.

Closing Date

Fund

Fund Type

Status

Amount

Sources

1/13/2020

10K Lakes Fund I

$26M

1

6/29/2018

SightLine Emerald SPV

$2.6M

1

4/25/2018

Sightline MS GP

$4.5M

1

11/16/2017

SightLine Optics SPV

$99M

10

8/7/2013

SightLine Healthcare Opportunity Fund II LP

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

1/13/2020

6/29/2018

4/25/2018

11/16/2017

8/7/2013

Fund

10K Lakes Fund I

SightLine Emerald SPV

Sightline MS GP

SightLine Optics SPV

SightLine Healthcare Opportunity Fund II LP

Fund Type

Subscribe to see more

Status

Subscribe to see more

Amount

$26M

$2.6M

$4.5M

$99M

$99M

Sources

1

1

1

10

10

SightLine Partners Team

7 Team Members

SightLine Partners has 7 team members, including current Managing Director, Buzz Benson.

Name

Work History

Title

Status

Buzz Benson

Managing Director

Current

Maureen Harder

Managing Director

Current

Scott Ward

General Partner

Current

Joe Biller

Managing Director

Former

Gary Blauer

Managing Director

Former

Name

Buzz Benson

Maureen Harder

Scott Ward

Joe Biller

Gary Blauer

Work History

Title

Managing Director

Managing Director

General Partner

Managing Director

Managing Director

Status

Current

Current

Current

Former

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.